Vdrl positive in pregnancy
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information to provide a thorough answer. Let me compile it.
VDRL Positive in Pregnancy
What is VDRL?
The Venereal Disease Research Laboratory (VDRL) test is a non-treponemal, non-specific screening test for syphilis (Treponema pallidum infection). A positive result in pregnancy requires prompt evaluation because of significant fetal risk.
Step 1: Confirm the Diagnosis — Is It True or False Positive?
A reactive VDRL must be followed by a confirmatory treponemal test:
| Confirmatory Test | Abbreviation |
|---|---|
| Fluorescent treponemal antibody absorption | FTA-ABS |
| T. pallidum particle agglutination assay | TP-PA |
Interpreting the results:
| VDRL | Treponemal Test | Interpretation |
|---|---|---|
| Reactive | Reactive | True positive → treat as syphilis |
| Reactive | Non-reactive | False positive → monitor (repeat in 4 weeks) |
| Reactive | Non-reactive + rising titer at 4 wks | Treat as syphilis |
In pregnancy, all seropositive women should be considered infected unless an adequate treatment history is documented and serial titers have declined.
— Creasy & Resnik's Maternal-Fetal Medicine
Causes of False-Positive VDRL
Pregnancy itself can cause a low-titre false-positive VDRL. Other causes:
- Viral/bacterial infections (atypical pneumonia, malaria)
- Autoimmune disorders (SLE — 8–20% of SLE patients have false-positive VDRL/RPR)
- Vaccinations
- Injection drug use, HIV, leprosy
- Advanced age (>1% at age 70, ~10% after age 80)
In most false-positive cases, the titer is <1:8. Very high titers are rarely false positive.
— Goldman-Cecil Medicine
Screening Protocol in Pregnancy
| Timing | Who |
|---|---|
| First prenatal visit | All pregnant women |
| 28–32 weeks | High-risk women |
| At labor admission | In high-prevalence areas |
| After stillbirth >20 weeks | All women |
Risks of Untreated Syphilis in Pregnancy
Untreated maternal syphilis causes:
| Stage | Risk of Congenital Syphilis |
|---|---|
| Primary / Secondary syphilis | ~50% |
| Early latent (<1 year) | ~40% |
| Late latent (>1 year) | ~10% |
Consequences include:
- Stillbirth (29%), neonatal death (14%)
- Preterm birth (~28%)
- Fetal growth restriction
- Congenital syphilis (jaundice, hydrops fetalis, skin lesions, bone involvement, CNS disease)
Treatment
Parenteral penicillin G is the only proven treatment in pregnancy — it treats maternal infection, prevents vertical transmission, and treats established fetal infection.
| Stage | Treatment |
|---|---|
| Primary, secondary, early latent | Benzathine penicillin G 2.4 million units IM × 1 dose |
| Late latent / unknown duration | Benzathine penicillin G 2.4 million units IM × 3 doses (weekly × 3 weeks) |
| Neurosyphilis | Aqueous crystalline penicillin G IV for 10–14 days |
Penicillin-allergic patients must undergo penicillin desensitization — tetracycline is contraindicated in pregnancy (fetal toxicity), and erythromycin is inadequate (does not cross the placenta reliably).
Post-treatment monitoring:
- Monthly quantitative VDRL titers
- A fourfold rise in titer = treatment failure/reinfection → retreat
- Expected decline: nonreactive or very low within 6–12 months (early syphilis) or 12–24 months (late syphilis)
Jarisch-Herxheimer Reaction
Up to 60% of early syphilis patients experience this within hours of treatment:
- Fever, myalgia, headache
- Exacerbation of skin lesions
- In pregnancy: may precipitate premature labor (rare)
- Managed symptomatically with NSAIDs; peaks at 6–8 hours, resolves within 24 hours
Congenital Syphilis — Neonatal Management
| Maternal History | Neonatal Action |
|---|---|
| No/inadequate treatment | Treat neonate at birth |
| Treated with non-penicillin drugs | Treat neonate |
| Treated adequately, titer stable | Monitor with serial monthly VDRL × 9 months |
| Rising infant titer | Active disease → treat |
Neonatal treatment:
- Normal CSF: Benzathine penicillin G 50,000 units/kg IM single dose
- Abnormal CSF: Aqueous penicillin G 50,000 units/kg IM/IV twice daily × 10 days minimum
Infected infants may be asymptomatic at birth with a normal VDRL if maternal infection was acquired late in pregnancy.
— Creasy & Resnik's Maternal-Fetal Medicine; Goldman-Cecil Medicine
Summary Flowchart
VDRL positive in pregnancy
↓
Confirmatory treponemal test (FTA-ABS / TP-PA)
↓ Positive ↓ Negative
True syphilis False positive
→ Treat immediately → Repeat quantitative RPR in 4 weeks
(Penicillin G) If titer rises 4-fold → Treat
→ Monthly VDRL If equivocal → Treat to protect neonate
→ Screen neonate at birth
This is a shared conversation. Sign in to Orris to start your own chat.